Christine Lovly

Oncology · 2012–2022

A researcher in the Science corpus: 5 papers; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Christine Lovly trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Fyodor A. Kondrashov
  2. Joseph Schlessinger
  3. Gerard Manning
  4. Nicolas Stransky
  5. Brian J. Druker
  6. M. Heinrich
  7. J. Kuriyan

Papers from Christine Lovly's perspective

Ordered by how strongly the researchers Christine Lovly trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. (New England Journal of Medicine)
  2. The conformational plasticity of protein kinases. (Cell)
  3. Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase* (Journal of Biological Chemistry)
  4. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. (Journal of Clinical Oncology)
  5. The Protein Kinase Complement of the Human Genome (Science)
  6. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. (Molecules and Cells)
  7. The landscape of kinase fusions in cancer (Nature Communications)
  8. ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
  9. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.
  10. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies (Nature Medicine)

Their papers